Comparison of short-term efficacy, side effects, benefits of two drospirenone containing combined oral contraceptives: 21/7-day-3mg/30mcg vs. 24/4-day-3mg/20 mcg

Tekeli, Arzu Esen; Dilbaz, Berna; Altınbaş, Şadıman Kıykaç; Tekın, Yeşim Bayoğlu

doi:10.1016/j.fertnstert.2012.07.706

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In case of persistence of the PMS/PMDD symptoms and/or presence of intermediate bleeding that does not improve after three month of COC use, the dosage of ethinyl estradiol can be increased and a 21+7 regimen with 3 mg DRSP/30 mcg ethinyl estradiol COC can be commenced. However, the 24/4 regimen is associated with better cycle control ( 72 ). The COC can be switched to an alternative formulation if drospirenone-containing COC fails to improve the symptoms or an SSRI can be added to COC monotherapy in order to improve the treatment results.…”

Section: Treatment With Combined Oral Contraceptivesmentioning

confidence: 99%

Premenstrual syndrome, a common but underrated entity: review of the clinical literature

Dilbaz

Aksan

2021

J Turkish German Gynecol Assoc

View full text Add to dashboard Cite

Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) are characterized by somatic and psychologic symptoms that arise at the luteal phase of the menstrual cycle and subside with menstruation. For definitive diagnosis prospectively self-reported symptoms should demonstrate a cyclic pattern and other psychological pathologies and thyroid dysfunction, that may present with similar symptoms, should be excluded. Both entities affect millions of women at reproductive age as the prevalence of PMS is given as 10-98% while PMDD affects 2-8%. Sex steroids and neurotransmitters have a central role in the etiology. The role of vitamins and minerals in the etiology and treatment of PMS and PMDD is open to discussion. Drugs that suppress ovarian sex steroid production, such as combined oral contraceptives or selective serotonin re-uptake inhibitors enhancing central serotonin delivery are used for treatment. Life-style changes and regular exercise also have a positive effect in milder cases. Tricyclic antidepressants and gonadotropin-releasing hormone analogues can be used in selected cases.

show abstract

Section: Treatment With Combined Oral Contraceptivesmentioning

confidence: 99%